JB/CALL/POLE GROU/24/0.1/20.09.24 | Market Closed - Swiss Exchange 08:50:00 31/05/2024 pm IST | ||
| 1.07 CHF | +9.18% |
|
| Current month | +18.89% | ||
| 1 month | +18.89% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 1.07 | +9.18% |
| 30/24/30 | 0.98 | +4.26% |
| 29/24/29 | 0.94 | -8.74% |
| 28/24/28 | 1.03 | -0.96% |
| 27/24/27 | 1.04 | +6.12% |
Delayed Quote Swiss Exchange
Last update May 31, 2024 at 08:50 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Bank Julius Bär |
| PPZZJB | |
| ISIN | CH1280666244 |
| Date issued | 14/08/2023 |
| Strike | 24 CHF |
| Maturity | 20/09/2024 (112 Days) |
| Parity | 10 : 1 |
| Emission price | 0.6 CHF |
| Emission volume | N/A |
| Settlement | both |
| Currency | CHF |
Technical Indicators
| Highest since issue | 1.13 CHF |
|---|---|
| Lowest since issue | 0.07 CHF |
| Spread | 0.01 CHF |
| Spread % | 0.93% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
34.09
EUR
Average target price
25.12
EUR
Spread / Average Target
-26.30%
- Stock Market
- Warrants
- PPZZJB Warrant
